Prasad Deepa - Insider Non-Derivative Transactions at Design Therapeutics, Inc. (DSGN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 18, 2024, Prasad Deepa's relationship to Design Therapeutics, Inc. (DSGN) is Director, and currently has 20,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DSGN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Prasad Deepa - Insider Non-Derivative Transactions of DSGN Common Stock

Prasad Deepa - Insider Non-Derivative Transactions at DSGN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 19, 2024	Sell -- (Common Stock)	3806	6.27	20000
Aug 30, 2023	P -- (Common Stock)	12000	2.31	23806